Congress took an important step to bring safe and effective treatments and cures to patients by passing the Food and Drug Administration (FDA) Reauthorization Act of 2017.
Improving Patient Safety and Information Technology Calls for Greater Leadership, Collaboration, and a Systems-Based Approach
BPC’s new report outlines recommendations for improving health IT’s role in providing safer care for patients while promoting innovation.
User fees play a critical role in providing the FDA the resources it needs to maintain the gold standard in both the review and approval of drugs
Timely completion and passage of FDA user fee reauthorization legislation is a crucial next step toward helping Americans in need.
The legislation will advance groundbreaking medical innovation and research that will help millions of Americans with life-threatening diseases.
BPC applauds FDA’s efforts to incorporate enhancements to accelerate the development and delivery of safe and effective treatments and cures to patients.
Through its extensive research with experts and practitioners, BPC identified numerous benefits for using real-world evidence to modernize drug development.